Pls refer the attachment
VIJAYA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Vijaya Diagnostic Centre Limited's Board approved audited standalone and consolidated financial results for Q4 and year ended March 31, 2026. The Board recommended a final dividend of ₹2 per equity share (200% on face value of ₹1) for FY2026, subject to shareholder approval at the AGM. Dr. D Nageshwar Reddy will not seek re-appointment for a second term as Independent Director effective May 25, 2026, citing pre-occupation and other professional commitments. The company granted 1,79,500 ESOPs to eligible employees at an exercise price of ₹784 per option (20% discount to 3-month average price). Additionally, the Board approved acquisition of MRI, EEG and NCV Services Business from its wholly-owned subsidiary Medinova Millennium MRI Services LLP for approximately ₹4.20 crore, consolidating diagnostic services operations.
The dividend declaration and ESOP grants signal management confidence in the company's financial health. The acquisition of diagnostic services business from the WOS at ₹4.20 crore is a strategic consolidation move that may streamline operations and improve profitability of the diagnostic chain.